SIRS-Lab Licenses OGT Chip Technology to Develop, Market Arrays | GenomeWeb

NEW YORK, March 18 (GenomeWeb News) - SIRS-Lab of Jena, Germany, has licensed Oxford Gene Technology's DNA chip patents to makes its own arrays and distribute them in Europe, the company said yesterday.

Privately held SIRS-Lab is developing microarray systems for inflammatory diseases.

The company said that the IP complements its Lab-Arraytor products and allows for the expansion of the product portfolio for new applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.